EUVIMEDEUVIMED entdecken
Multizentrische StudieEvaluationsstudieVergleichsstudieOpen Access · CC BY-NC 4.0

Multicenter Evaluation of the QIAstat‐Dx and the BioFire Multiplex Panel Tests for the Detection of Respiratory Pathogens

Rainer Gosert iD, Roger Koller iD, Jakob Meyer, Sarah Dräger iD, Alban Ramette, Roland Bingisser, Christian H Nickel, Stefano Bassetti, Sarah Tschudin Sutter, Peter M Keller iD, Pascal Bittel, Karoline Leuzinger iD

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.70129 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Rainer Gosert und 11 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Virology, University Hospital Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Respiratory Tract Infections, Viruses. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Syndromic multiplex panel testing enables simultaneous detection of multiple respiratory pathogens, but limited data is available on the comparative diagnostic performance of different testing systems. In this multicenter prospective study, we aimed to compare the QIAstat‐Dx Respiratory Panel 2.0 (QIAstat‐Dx‐RP2.0) with the widely used BioFire‐RP2.1, using 269 respiratory clinical specimens. Concordant test results were obtained in 232 (86.3%) cases. Discordant test results included 33 BioFire‐RP2.1(+)/QIAstat‐Dx‐RP2.0(−) and 4 BioFire‐RP2.1(‐)/QIAstat‐Dx‐RP2.0(+) results. Discordant samples showed significantly lower pathogen loads than concordant ones ( p < 0.01). Overall, the QIAstat‐Dx‐RP2.0 showed an analytical sensitivity of 50%–100% depending on the respiratory target, with an analytical specificity ≥ 99.0%. Most significant differences were found for the detection of adenovirus, human coronaviruses, respiratory syncytial virus, human rhinovirus/enterovirus and SARS‐CoV‐2 (kappa‐score: 0.67–0.91). Co‐detections of respiratory pathogens were identified in 47 cases by BioFire‐RP2.1 and 29 by QIAstat‐Dx‐RP2.0. Agreement rates between the two multiplex panel tests decreased from 91.8% for single pathogen detections to 65.0% and 42.9% for co‐detecting two and three pathogens, respectively. Pathogen loads were significantly lower in co‐detections compared to single pathogen detections ( p < 0.01), potentially explaining the lower detection rates with the QIAstat‐Dx‐RP2.0 in cases of multiple pathogens. In conclusion, our prospective multicenter evaluation showed good diagnostic performance of the QIAstat‐Dx‐RP2.0 assay, but lower detection rates for some respiratory targets compared to BioFire‐RP2.1. As QIAstat‐Dx‐RP2.0 offers advantages in handling, noise emission, cost effectiveness, and provides semi‐quantitative results compared to BioFire‐RP2.1 an updated version with enhanced analytical sensitivity would be a viable alternative syndromic testing system for detecting respiratory pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Tract InfectionsVirusesAdolescentAdultAgedAged, 80 and overChildChild, PreschoolFemaleHumansInfantMaleMiddle AgedYoung AdultCOVID-19Molecular Diagnostic TechniquesMultiplex Polymerase Chain ReactionProspective StudiesSARS-CoV-2Sensitivity and Specificity

Stichwörter der Autor:innen

BioFireQIAstat‐DxRSVSARS‐CoV‐2adenovirusinfluenzarespiratory pathogenrespiratory tract infectionrhinovirus/enterovirussyndromic multiplex panel testing

Autor:innen und Institutionen

  • Clinical Virology, University Hospital Basel, Basel, Switzerland.
  • Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
  • Emergency Medicine, University Hospital Basel, Basel, Switzerland.
  • Internal Medicine, University Hospital Basel, Basel, Switzerland.
  • Infectious Diseases & Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
  • Clinical Bacteriology/Mycology, University Hospital Basel, Basel, Switzerland.

ORCID-Profile: Rainer Gosert, Roger Koller, Sarah Dräger, Peter M Keller, Karoline Leuzinger

Zitieren

APA

Gosert, R., Koller, R., Meyer, J., Dräger, S., Ramette, A., Bingisser, R., Nickel, C. H., Bassetti, S., Sutter, S. T., Keller, P. M., Bittel, P., & Leuzinger, K. (2024). Multicenter Evaluation of the QIAstat‐Dx and the BioFire Multiplex Panel Tests for the Detection of Respiratory Pathogens. Journal of Medical Virology. https://doi.org/10.1002/jmv.70129

Vancouver

Gosert R, Koller R, Meyer J, Dräger S, Ramette A, Bingisser R, et al. Multicenter Evaluation of the QIAstat‐Dx and the BioFire Multiplex Panel Tests for the Detection of Respiratory Pathogens. Journal of Medical Virology. 2024. doi:10.1002/jmv.70129

BibTeX
@article{Gosert2024,
  author = {Gosert, Rainer and Koller, Roger and Meyer, Jakob and Dräger, Sarah and Ramette, Alban and Bingisser, Roland and Nickel, Christian H and Bassetti, Stefano and Sutter, Sarah Tschudin and Keller, Peter M and Bittel, Pascal and Leuzinger, Karoline},
  title = {Multicenter Evaluation of the QIAstat‐Dx and the BioFire Multiplex Panel Tests for the Detection of Respiratory Pathogens},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.70129}
}
Kostenlos starten →